News for AVEO Pharmaceuticals, Inc. (AVEO)

“Cancer Cachexia Market” from 2024-2034 with covered segments By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Mechanism...

CORRECTION “ AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee

The capital injection accounts for 65% LG’s annual global investment.

– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of...

According to Straits Research, “The global cancer cachexia market size was worth USD 2.47 billion in 2022, and it is estimated to reach an expected value...

Phase 3 Registrational Trial Seeks to Improve Survival Outcomes in Underserved HPV-negative R/M Head and Neck Cancer Patient PopulationTrial Launch Follows...

On track to dose 20 total patients in the EDIT-301 RUBY trial for SCD and provide a clinical update by year-end Commenced parallel patient dosing in the EDIT-301 EDITHAL trial for TDT and on...

Cancer Cachexia Market Trends and Insights by Drug Therapy (Progestogens, Corticosteroids, Combination Therapies), Mode of Action (Weight Loss Stabilizers...

/PRNewswire/ -- The

GuruFocus Article or News written by insider and the topic is about:

DelveInsight’s liver cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for liver cancer...

In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech

On Thursday morning, 420 companies hit new 52-week highs. Significant Points: The largest company by market cap to hit a new 52-week high was Visa ...

Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA must...

Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities passed FDA muster. NME ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X ...

JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week's J.P. Morgan Healthcare Conference. After end...